Methods of preventing and retarding the progression of myopia

Ewa Grudzińska, Anna Fabian-Danielewska, Magdalena Gibka


Myopia is an increasing problem worldwide. Its prevalence is predicted to over 4 billion of people in 2050, what would be almost 50% of the population. Therefore, authors have analyzed available literature in terms of treatment that may be able to prevent or slow the progression of myopia. There are risk factors such as genetic factors which nowadays could not be modified. However, there are other risk factor such as near work or protective factor such as time spent outdoor which could be modified. Moreover, therapeutic interventions seem to play more significant role. Among available methods it is mentioned: pharmacology including drops of atropine and pirenzepine, undercorrection, contact lenses, orthokeratology, bifocal or multifocal spectacles and soft multifocal contact lenses. Methods are described with their mechanism of action and efficacy.


myopia; prevention; therapy; progression

Full Text:



Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010 British Journal of Ophthalmology 2012;96:614-618.

Dolgin E. The myopia boom. Nature. 2015 Mar 19;519(7543):276-8. doi:10.1038/519276a. PubMed PMID: 25788077.

Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS et al (2017) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 124(3): 24-25

Mutti DO, Mitchell GL, Moeschberger ML, et al. Parental myopia near school achievement and children’s refractive error. Invest Ophthalmol Vis Sci 2002;43:3633–3640

Verhoeven VJ, et al., 2013. Genome-wide meta-analyses of multi-ancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nature Genetics 45:314-318. doi:10.1038/ng.2554.

Huang HM, Chang DS, Wu PC. The Association between Near Work Activities and Myopia in Children-A Systematic Review and Meta-Analysis. PLoS One. 2015 Oct 20;10(10):e0140419. doi: 10.1371/journal.pone.0140419. eCollection 2015. Review. PubMed PMID: 26485393; PubMed Central PMCID: PMC4618477.

Sherwin, J. C., Reacher, M. H., Keogh, R. H., Khawaja, A. P., Mackey, D. A., & Foster, P. J. (2012). The Association between Time Spent Outdoors and Myopia in Children and Adolescents. Ophthalmology, 119(10), 2141–2151.doi:10.1016/j.ophtha.2012.04.020

Siatkowski RM, Cotter SA, Crockett RS, Miller JM, Novack GD, Zadnik K; U.S. Pirenzepine Study Group. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J AAPOS. 2008 Aug;12(4):332-9. doi: 10.1016/j.jaapos.2007.10.014. Epub 2008 Mar 24. PubMed PMID: 18359651.

Siatkowski RM, Cotter S, Miller JM, Scher CA, Crockett RS, Novack GD; US. Pirenzepine Study Group. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. Arch Ophthalmol. 2004 Nov;122(11):1667-74. PubMed PMID: 15534128.

Pineles SL, Kraker RT, VanderVeen DK, Hutchinson AK, Galvin JA, Wilson LB, Lambert SR. Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 Dec;124(12):1857-1866. doi: 10.1016/j.ophtha.2017.05.032. Epub 2017 Jun 29. Review. PubMed PMID: 28669492.

Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019 Jan;126(1):113-124. doi: 10.1016/j.ophtha.2018.05.029. Epub 2018 Jul 6. PubMed PMID: 30514630.

Walline JJ. Myopia Control: A Review. Eye Contact Lens. 2016 Jan;42(1):3-8. doi: 10.1097/ICL.0000000000000207. Review. PubMed PMID: 26513719.

Sun, Y.-Y., Li, S.-M., Li, S.-Y., Kang, M.-T., Liu, L.-R., Meng, B., Wang, N. (2016). Effect of uncorrection versus full correction on myopia progression in 12-year-old children. Graefe’s Archive for Clinical and Experimental Ophthalmology, 255(1), 189–195.doi:10.1007/s00417-016-3529-1

Chung K, Mohidin N, O'Leary DJ. Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res. 2002 Oct;42(22):2555-9.PubMed PMID:12445849.

Sankaridurg, P. (2017). Contact lenses to slow progression of myopia. Clinical and Experimental Optometry, 100(5), 432–437.doi:10.1111/cxo.12584

Koffler, B. H., & Sears, J. J. (2013). Myopia Control in Children through Refractive Therapy Gas Permeable Contact Lenses: Is it for Real? American Journal of Ophthalmology, 156(6), 1076–1081.e1. doi:10.1016/j.ajo.2013.04.039

Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004916. doi: 10.1002/14651858.CD004916.pub3. Review.PubMed PMID: 22161388; PubMed Central PMCID: PMC4270373.

Robboy, M. W., Hilmantel, G., Tarver, M. E., & Eydelman, M. B. (2018). Assessment of Clinical Trials for Devices Intended to Control Myopia Progression in Children. Eye & Contact Lens: Science & Clinical Practice, 1.doi:10.1097/icl.0000000000000476



  • There are currently no refbacks.

Copyright (c) 2019 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski